Market Tracker

06/27 5:16pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

10.00
Delayed Data
As of 3:59pm ET
 -0.35 / -3.38%
Today’s Change
3.20
Today|||52-Week Range
17.50
+153.16%
Year-to-Date
Biotech Stocks Finally Stage Breakthrough
Jun 22 / TheStreet.com - Paid Partner Content
Dynavax Technologies (DVAX) Catches Eye: Stock Gains 6.6%
Jun 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close10.35
Today’s open10.35
Day’s range9.90 - 10.53
Volume2,308,285
Average volume (3 months)1,590,456
Market cap$505.0M
Dividend yield--
Data as of 3:59pm ET, 06/27/2017

Growth & Valuation

Earnings growth (last year)+10.15%
Earnings growth (this year)+30.65%
Earnings growth (next 5 years)--
Revenue growth (last year)+172.67%
P/E ratioNM
Price/Sales13.77
Price/Book4.48

Competitors

 Today’s
change
Today’s
% change
RARXRa Pharmaceuticals I...-4.49-20.24%
SCMPSucampo Pharmaceutic...-0.35-3.26%
TLGTTeligent Inc-0.05-0.54%
GTHXG1 Therapeutics Inc+0.20+1.11%
Data as of 3:59pm ET, 06/27/2017

Financials

Next reporting dateJuly 26, 2017
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$11.0M
Annual profit (last year)-$112.4M
Net profit margin-1,018.24%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts